The major theme of his research program is to identify genetic factors involved in the initiation or progression of common kidney diseases, as potential targets for developing novel diagnostic tests and therapies. His research focuses on genetic, genomic and translational research of several hereditary kidney disorders including autosomal dominant polycystic kidney disease, IgA nephropathy and idiopathic nephrotic syndrome, and is supported by grants from the Kidney Foundation of Canada, Physicians Incorporated Foundation, and Canadian Institutes of Health Research.
Dr. Pei is a Professor of Medicine at the University of Toronto. He is also a staff nephrologist at the Toronto General Hospital, University Health Network, where he directs the Center for Innovative Management for Polycystic Kidney Disease. He received research training in both Clinical Epidemiology and Human Molecular Genetics. His research program focuses on genetic, genomic, and translational research of hereditary kidney diseases with a major focus on autosomal dominant polycystic kidney disease and is supported by grants from the Kidney Foundation of Canada, Physicians Incorporated Foundation, Polycystic Kidney Disease Foundation (both USA and Canada), and the Canadian Institutes of Health Research.
He has published more than 100 peer-reviewed articles and has served on the Editorial Board for the Journal of the American Society of Nephrology and Grant Review Panels for the Kidney Foundation of Canada, Canadian Institutes of Health Research, PKD foundation (USA), and National Institutes of Health (USA). He was a co-recipient of the 2019 Lillian J. Kaplan International Prize (link is external) for Advancement in the Understanding of Polycystic Kidney Disease.